TrialEye (London, England)2022

Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial.

Assaf Gershoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.